Clinical outcomes of pediatric kidney replacement therapy after childhood cancer-An ESPN/ERA Registry study
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39515759
DOI
10.1016/j.ajt.2024.11.002
PII: S1600-6135(24)00686-5
Knihovny.cz E-zdroje
- Klíčová slova
- cancer, children, kidney replacement therapy, kidney transplantation, malignancy, mortality,
- MeSH
- chronické selhání ledvin * mortalita etiologie terapie MeSH
- dítě MeSH
- hodnoty glomerulární filtrace MeSH
- kojenec MeSH
- lidé MeSH
- míra přežití MeSH
- mladiství MeSH
- nádory * komplikace mortalita MeSH
- náhrada funkce ledvin * mortalita MeSH
- následné studie MeSH
- předškolní dítě MeSH
- přežívání štěpu MeSH
- prognóza MeSH
- registrace * MeSH
- rejekce štěpu * mortalita etiologie MeSH
- rizikové faktory MeSH
- studie případů a kontrol MeSH
- transplantace ledvin * mortalita MeSH
- vyšetření funkce ledvin MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Cancer and its treatment may lead to kidney injury and the need for kidney replacement therapy (KRT). We identified 287 pediatric KRT patients with a history of malignancy from the European Society for Paediatric Nephrology/European Renal Association Registry. Of these, 197 had cancer as a primary cause of KRT (group 1) and 90 had a malignancy diagnosis before KRT (group 2). Two matched controls without malignancy were randomly selected for each patient. Data were complemented with a questionnaire. Median time to kidney transplantation (KT) from KRT initiation was 2.4 (IQR: 1.5-4.7), 1.5 (IQR: 0.4-3.3), 3.6 (IQR: 1.3 to Q3 not reached), and 1.1 (IQR: 0.3-3.6) years for group 1, their controls, group 2, and their controls, respectively. Overall 10-year mortality for those on KRT was higher among cancer patients vs controls in group 1: 16% vs 9% (adjusted hazard ratio 2.02, 95% CI: 1.21-3.37) and in group 2: 23% vs 14% (adjusted hazard ratio 2.32, 95% CI: 1.11-4.85). In contrast, 10-year patient survival after the first KT was comparable to controls (93% vs 96%; 100% vs 94%, in groups 1 and 2, respectively). In summary, childhood cancer survivors' KT was delayed, and their overall mortality when on KRT was increased, but once transplanted, their long-term outcome was similar to other KT recipients.
Department of Cardiology Endocrinology and Nephrology Holbaek Hospital Holbaek Denmark
Department of Pediatric Nephrology Hôpital Robert Debré Assistance Publique Hôpitaux de Paris France
Department of Pediatric Nephrology Medical University of Lublin Lublin Poland
Department of Pediatric Nephrology University Hospitals Leuven Leuven Belgium
Department of Pediatrics Medical University Graz Graz Austria
Division of Paediatric and Adolescent Medicine Oslo University Hospital Oslo Norway
Nephrology Department Meyer Children's Hospital University of Florence Florence Italy
Paediatric Nephrology Department Hospital La Paz Madrid Spain
Pediatric Nephrology Division Pediatric Department Unidade Local de Santo António Porto Portugal
Pirogov Russian National Research Medical University Moscow Russia
Citace poskytuje Crossref.org